Amedisys's change in receivables for the quarter that ended in Mar. 2024 was $-47 Mil. It means Amedisys's Accounts Receivable
increased by $47 Mil
from Dec. 2023 to Mar. 2024 .
Amedisys's change in receivables for the fiscal year that ended in Dec. 2023 was $-27 Mil. It means Amedisys's Accounts Receivable
increased by $27 Mil
from Dec. 2022 to Dec. 2023 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Amedisys's Days Sales Outstanding for the
three
months ended in Mar. 2024 was 57.39.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Amedisys's liquidation value for the
three
months ended in Mar. 2024 was $-569 Mil.
Amedisys Change In Receivables Historical Data
The historical data trend for Amedisys's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amedisys (NAS:AMED) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Amedisys's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amedisys Change In Receivables Related Terms
Thank you for viewing the detailed overview of Amedisys's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMED has been successfully added to your 